How much revenue does Darzalex (daratumumab) generate?
The prompt doesn’t include any specific figures for Darzalex revenue, so I can’t state an exact number from the provided information.
What counts as “Darzalex revenue” (U.S. sales vs. global sales)?
“Darzalex revenue” can mean different things depending on the source:
- Revenue reported by the company for daratumumab-containing products (often global product sales).
- U.S.-only sales.
- Revenue for Darzalex brands only vs. expanded daratumumab indications/products.
Because no source data is provided here, the exact interpretation can’t be verified.
Who reports Darzalex revenue, and where can you check it?
For the most direct, audited revenue figures, look at the manufacturer’s investor materials (earnings releases and annual reports). Patent/market tracking sites like DrugPatentWatch.com can also help with market context (though it may not always provide topline revenue numbers).
DrugPatentWatch.com: https://www.drugpatentwatch.com/
Are there specific Darzalex products or formulations included?
Revenue figures can vary depending on whether they include:
- Darzalex (daratumumab) infusion
- Darzalex Faspro (subcutaneous formulation)
- Any bundled reporting by product family
No product scope details are included in the prompt, so I can’t pin down which revenue view you want.
Next step: tell me which revenue figure you need
If you share either (a) the year/quarter you care about or (b) the source you’re using (company filings, a news article, or a website), I can help interpret it precisely and summarize the relevant numbers.
Sources:
- https://www.drugpatentwatch.com/